pharmaphorum

FEBRUARY 1, 2022

Attendees will learn more about how an SCA was used at the design and execution phases in a recent study of new treatments for relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) and will also receive an eBook ‘How to harness the potential of AI and real-world data for clinical research’. About the panel.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

pharmaphorum

MAY 25, 2021

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine. But, until recently, an important data source has been locked up in the electronic health record (EHR), often in the form of unstructured or ‘free’ text entered by healthcare professionals.

Big Data 135

Big Data Clinical Research Research Trials 135

Drug Discovery World

FEBRUARY 6, 2023

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

Big Data 52

Big Data RNA Bioinformatics Vaccination 52

Drug Discovery World

DECEMBER 20, 2022

The company also predicts a shift to democratised and digitised healthcare data, a prioritisation of real-world data, and recognition of the role of ‘clinical inertia’ in the uptake of new treatments. . AI will take on a wider role. M&A activity will accelerate.

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

The Pharma Data

JANUARY 12, 2021

Following its most recent financing round , Massive Bio’s trial enrollment platform has been evolving into a command center to supply research stakeholders with real-time communications, data, and enhanced analytics. “The These patients can be anywhere waiting to get access to a clinical trial.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Navigating rare disease research and treatment.

Genome 105

Genome Genomics Research Medicine 105

Drug Discovery World

OCTOBER 12, 2022

10-15 years ago, there were few validated medical devices for clinical research, and now we have a lot of technology to choose from. Companies are using sensors that we can put on our wrist or chest and capture all types of data. What are the challenges using sensors in clinical trials? About the author .

Clinical Trials 52

Clinical Trials Clinical Trials Trials Sales 52

Roots Analysis

DECEMBER 29, 2023

Clinical trials are prospective biomedical research studies designed to evaluate medical, surgical or behavioral interventions in people and investigate novel approaches for the diagnosis and prevention / treatment of diseases. Clinical research can be classified into two types: observational studies and clinical trials.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Research 40

Crucial Data Soutions

JUNE 12, 2019

Although approach differs slightly amongst organizations in clinical research, everyone agrees on this: it’s time for the industry to become more agile. Too many life-saving treatments and medical advancements are at stake to remain attached to the traditional ways of data collection.

Clinical Trials 40

Clinical Trials Clinical Trials Trials Research 40

Pharmaceutical Technology

NOVEMBER 1, 2022

In a few weeks, the EU-funded research project Darwin EU will announce its first batch of data partners for the ambitious real-world data -driven Horizon 2020 project. A major objective of this project hinges on exploiting national EHR data to complete observational studies quicker than industry standards.

Big Data 278

Big Data Regulation Medicine Research 278

Cloudbyz

SEPTEMBER 25, 2020

HEPAprint, MEDIKURA, Navro, Embleema & Cloudbyz develop 5 top solutions to watch out for. For this research, we identified 164 relevant solutions and picked 5 to showcase below. The Global Startup Heat Map below highlights 5 startups & emerging companies developing pharmacovigilance solutions.

Pharma Companies 52

Pharma Companies Big Data Drugs Clinical Trials 52

pharmaphorum

DECEMBER 22, 2021

Rise of the machines – big data, AI and machine learning. Companies will capitalise on tech advances in the areas of data use to inform R&D and/or provide personalised care to patients. Patients are beginning to expect the providers of their medicines to help them with their condition and the impact on their lives.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Pharma Companies 105

pharmaphorum

MARCH 16, 2021

International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health records (EHRs) using artificial intelligence (AI) and clinical Natural Language Processing (NLP) techniques. AI use in the pandemic.

Doctors 116

Doctors Doctor Life Science Clinical Research 116

Cloudbyz

MAY 16, 2021

This is a relatively new model of clinical trials in terms of adoption and is, therefore, the highly underutilized method of conducting clinical research. Undoubtedly, virtual clinical trials leverage the power of tele-health/digital technology by including virtual patient monitoring, wearable medical devices, remote SDV, etc.

Clinical Trials 52

Clinical Trials Clinical Trials Trials Clinical Research 52

Pharmaceutical Technology

MAY 9, 2023

Meanwhile, decentralisation and the Big Data revolution are transforming the way researchers run clinical trials, and previously untapped geographies are emerging as new hubs for future research. Clinical trials management is no exception.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Big Data 130

The Pharma Data

JANUARY 17, 2021

There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. Syntegra has also engaged with the Federal Drug Administration (FDA) to evaluate the role of synthetic data in regulatory decisions, for COVID-19 and beyond. .

Life Science 52

Life Science Engineer Big Data Scientist 52